These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8868510)

  • 1. Poor correlation between soluble fibrin concentrations measured by two commercially available immunoassays.
    Rahr HB; Danielsen D; Andersen BS; Borris LC; Lassen MR
    Thromb Res; 1996 Mar; 81(6):607-14. PubMed ID: 8868510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of immunological and functional assays for measurement of soluble fibrin.
    Dempfle CE; Pfitzner SA; Dollman M; Huck K; Stehle G; Heene DL
    Thromb Haemost; 1995 Aug; 74(2):673-9. PubMed ID: 8585005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of soluble fibrin: a comparison of four different methods.
    Wieding JU; Hosius C
    Thromb Res; 1992 Mar; 65(6):745-56. PubMed ID: 1636166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease.
    Hetland Ø; Knudsen A; Dickstein K; Nilsen DW
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):301-8. PubMed ID: 12032395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
    Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y
    Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer.
    Dempfle CE; Zips S; Ergül H; Heene DL;
    Thromb Haemost; 2001 Nov; 86(5):1204-9. PubMed ID: 11816708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of enzyme immunoassays for determination of thyroxine (EMIT, ENZYMUN) and of thyroxine binding index.
    Oellerich M; Haindl H; Haeckel R
    J Clin Chem Clin Biochem; 1979 Jul; 17(7):483-8. PubMed ID: 383883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin monomer antigen: a novel marker of mortality in acute myocardial infarction.
    Kontny F; Dempfle CE; Abildgaard U
    Eur Heart J; 1999 Jun; 20(11):808-12. PubMed ID: 10329078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of sensitivity and specificity of six D-dimer latex assays.
    Charles LA; Edwards T; Macik BG
    Arch Pathol Lab Med; 1994 Nov; 118(11):1102-5. PubMed ID: 7979895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of a commercially available enzyme linked immunosorbent assay (ELISA) for the determination of thyroxine in canine plasma samples.
    Jensen AL; Høier R; Poulsen JS
    Zentralbl Veterinarmed A; 1992 Dec; 39(10):741-6. PubMed ID: 1492506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A soluble fibrin standard: comparable dose-response with immunologic and functional assays.
    McCarron BI; Marder VJ; Kanouse JJ; Francis CW
    Thromb Haemost; 1999 Jul; 82(1):145-8. PubMed ID: 10456469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Soluble fibrin and D-dimer at normal pregnancy and pregnancy with risk of miscarriage].
    Lugovskoĭ EV; Kolesnikova IN; Lugovskaia NE; Gritsenko PG; Litvinova LM; Gogolinskaia GK; Liashko ED; Kostiuchenko EP; Golota VIa; Kurochka VV; Komisarenko SV
    Ukr Biokhim Zh (1999); 2006; 78(4):120-9. PubMed ID: 17236629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of methods for detecting soluble fibrin in plasma. An in vitro study.
    Halvorsen S; Skjønsberg OH; Ruyter R; Godal HC
    Thromb Res; 1990 Feb; 57(4):489-97. PubMed ID: 2326770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay.
    Wiman B; Rånby M
    Thromb Haemost; 1986 Apr; 55(2):189-93. PubMed ID: 3087001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score.
    Dempfle CE; Wurst M; Smolinski M; Lorenz S; Osika A; Olenik D; Fiedler F; Borggrefe M
    Thromb Haemost; 2004 Apr; 91(4):812-8. PubMed ID: 15045145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble fibrin in plasma before and after surgery for benign and malignant colorectal disease.
    Iversen LH; Thorlacius-Ussing O; Okholm M
    Thromb Res; 1995 Sep; 79(5-6):471-81. PubMed ID: 7502273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of soluble fibrin in patients with venous thromboembolism.
    Tsuji A; Wada H; Matsumoto T; Abe Y; Ota S; Yamada N; Sugiyama T; Sudo A; Onishi K; Nakatani K; Uchida A; Ito M; Suzuki K; Nobori T
    Int J Hematol; 2008 Nov; 88(4):448-453. PubMed ID: 18836793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a soluble fibrin assay in patients with suspected deep vein thrombosis.
    Ginsberg JS; Siragusa S; Douketis J; Johnston M; Moffat K; Stevens P; Brill-Edwards P; Panju A; Patel A
    Thromb Haemost; 1995 Sep; 74(3):833-6. PubMed ID: 8571306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.
    Ieko M; Nakabayashi T; Tarumi T; Naito S; Yoshida M; Kanazawa K; Mizukami K; Koike T
    Clin Chim Acta; 2007; 386(1-2):38-45. PubMed ID: 17803984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.